Recombinant IL23A (Tildrakizumab Biosimilar) 抗体
This anti-IL23A (Tildrakizumab Biosimilar) antibody is a Mammalian Cells 单克隆 antibody detecting IL23A (Tildrakizumab Biosimilar) in ELISA. Suitable for 人.
产品编号 ABIN7488009
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for Recombinant IL23A (Tildrakizumab Biosimilar) 抗体 (ABIN7488009)
抗原
IL23A (Tildrakizumab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Mammalian Cells
克隆类型
单克隆
标记
This IL23A (Tildrakizumab Biosimilar) antibody is un-conjugated
应用范围
ELISA
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Tildrakizumab Biosimilar - Anti-IL23A mAb
-
产品特性
- Antibody Type: IgG1-kappa
-
纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
-
亚型
- IgG1 kappa
-
-
-
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS pH 7.5
-
储存条件
- -80 °C
-
储存方法
- store at -80°C
-
-
- IL23A (Tildrakizumab Biosimilar)
-
物质类
- Biosimilar
-
背景
-
MK-3222, SCH900222
Tildrakizumab is a humanized IgG1 kappa antibody that targets interleukin 23 p19 with high affinity. It is investigated for the treatment of chronic plaque psoriasis. -
CAS-编号
- 1326244-10-3
抗原
-
You are here:
